Ascendiant Capital Markets Forecasts Strong Price Appreciation for IGC Pharma (NYSEAMERICAN:IGC) Stock
IGC Pharma (NYSEAMERICAN:IGC – Get Free Report) had its price objective upped by equities research analysts at Ascendiant Capital Markets from $5.25 to $5.50 in a report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. IGC Pharma Stock Performance Shares of NYSEAMERICAN IGC opened at $0.29 on Monday. The […]
8 Jun 12:04 · The Markets Daily